Epithalon price: $50.00 list, $25.00 with the code
The Epithalon price on the listing we link is $50.00 for a 10 mg lyophilised vial, reduced from a $69.99 original, and the code PEPTIDEDECK takes that to $25.00. Ten milligrams on the label divides into $2.50 per milligram. Both figures were read off the listing on 23 August 2026.
Per milligram is the unit worth carrying out of this page, because vial sizes are not standardised across research suppliers and a headline price tells you nothing until you know what is in the vial. It is also the unit that makes the next section possible, because the label quantity and the measured quantity on this batch are not the same number.
What $25.00 buys is 10 mg of a synthetic tetrapeptide: four residues in the order Ala-Glu-Asp-Gly, sometimes written AEDG. PubChem lists it as CID 219042, formula C14H22N4O9, molecular weight 390.35. FDA and PubChem spell it Epitalon; the buying market spells it Epithalon. Same molecule, two spellings, and a page that treats them as different compounds is not reading its own sources.
One supplier is linked on this page and we earn a commission if you buy through it, which our affiliate disclosure sets out in full. That is why the list price sits here next to the discounted one, why the fill weight gets its own section, and why the section on what $25.00 does not buy has not been trimmed.
| What you are looking at | Price | Per mg, label | Per mg, assayed |
|---|---|---|---|
| Original price, 10 mg lyophilised vial | $69.99 | $7.00 | $7.26 |
| Current list price | $50.00 | $5.00 | $5.19 |
| With the code PEPTIDEDECK | $25.00 | $2.50 | $2.59 |
| A compounded Epithalon prescription | Does not exist | No approval, no bulks-list entry | Nothing to measure |
| An insurer or savings-card price | Does not exist | No national drug code to bill against | Nothing to measure |
Prices read off the product listing on 23 August 2026. Label basis uses the 10 mg stated quantity; assayed basis uses the 9.64 mg measured on batch 15-05260628.
The second figure: $2.59 per milligram on the assayed vial
The certificate for this batch does something most listings never do. It reports a measured net content rather than repeating the label back at you, and the number it reports is 9.64 mg in a vial labelled 10 mg. The specification on the document is 10 mg plus or minus 10 percent, so 9.64 mg passes. It is also, plainly, under the label.
Do the arithmetic on what you are actually buying and the price moves. $25.00 divided by 9.64 mg is $2.59 per milligram, not $2.50. At the undiscounted $50.00 the same vial is $5.19 per milligram rather than $5.00. The gap is about 3.7 percent, which is not dramatic, and rounding it away would still be the wrong instinct: the whole reason to compute a per milligram figure is that it reflects the material, and here the material has been weighed.
The disclosure deserves credit even as the arithmetic goes against the vendor. A supplier that publishes a fill weight slightly below its own label is telling you something useful about how it handles documents, which is more informative than a certificate that simply asserts 10 mg. Compare it with the direction the neighbouring compound went: one Selank listing publishes a lot assaying 12.29 mg against a 10 mg label, roughly 23 percent over. Both are honest documents. Only one of them flatters the seller.
The full certificate covers batch 15-05260628, issued by Kovera Labs as report KVR-2026-A36FF4 and certified on 23 May 2026: the PDF is published on the product page. Purity is 99.312 percent against a stated specification of greater than 98 percent, identity is confirmed, a bacterial endotoxin screen against a 0.5 EU/mL limit passes, a microbial sterility screen shows no growth, and heavy metals including arsenic, cadmium and mercury were screened.
How much does Epithalon cost at three, five and ten vials
How much does Epithalon cost changes once quantity enters, and the listing publishes its tiers rather than hinting at them. Three vials take 3 percent off the list price, five take 5 percent and ten take 10 percent. On a $50.00 vial that is $1.50, $2.50 and $5.00 off each one, so $48.50, $47.50 and $45.00 apiece, and order totals of $145.50, $237.50 and $450.00.
Free shipping starts once an order passes $250, and this is where the tier maths surprises people. Five vials at $237.50 do not clear the threshold. Ten vials do. Three and five both leave shipping on the bill, so the tier that looks like the sensible middle is not buying you the thing buyers assume it buys.
The more important point is that every published tier is a worse unit price than the code. Ten percent off list works out at $4.50 per milligram on the label basis, or $4.67 on the assayed quantity. The code works out at $2.50 and $2.59. Both discounts come off the same $50.00 list price, and whether they combine is settled at the checkout rather than by any published policy, so no stacked figure is printed here. Build the cart both ways and compare the totals on screen before a card goes in.
There is one non-financial argument for buying more than one vial. A certificate is batch specific, so several vials from one batch are covered by a document you have already read, where vials bought across a year are several batches and several documents, and later batches carry no obligation to repeat the same tests. Set that against the size of an order with no return path beyond the vendor's own policy.
| Quantity | Off each vial | Per vial | Order total | Per mg, label | Free shipping over $250 |
|---|---|---|---|---|---|
| 1 | None | $50.00 | $50.00 | $5.00 | No |
| 1 with the code | $25.00 | $25.00 | $25.00 | $2.50 | No |
| 3 | $1.50 | $48.50 | $145.50 | $4.85 | No |
| 5 | $2.50 | $47.50 | $237.50 | $4.75 | No |
| 10 | $5.00 | $45.00 | $450.00 | $4.50 | Yes |
Tier arithmetic as published on the listing. Tiers discount the list price, and so does the code. Whether the two combine is not documented anywhere we can cite.
Why no prescription Epithalon price exists in the United States
On the medicines this site usually covers there are at least three prices for one molecule: a manufacturer list price, a cash price somebody negotiated, and whatever a plan leaves the patient holding. That structure is the whole subject of our guide to what GLP-1 care actually costs. Epithalon has one price, from one kind of seller.
The reason is regulatory rather than commercial. Epitalon holds no FDA approval for any indication, so there is no approved product, no national drug code and no formulary position to occupy. The compounded route is closed as well. A pharmacy compounding under section 503A of the Federal Food, Drug and Cosmetic Act may work from a bulk drug substance only where that substance has a United States Pharmacopeia or National Formulary monograph, is a component of an approved drug product, or appears on FDA's 503A bulks list. Epitalon satisfies none of the three.
The bulks-list detail is where competing pages go wrong, so state it precisely. Epitalon was nominated, was placed in category 2 under FDA's interim policies while the agency evaluated it, and the nomination was then withdrawn. It appears on no current category list at all, in the lists updated 14 May 2026. Nominated and withdrawn is the accurate description. Category 2 is stale. Banned is a word nobody at the agency used.
For price comparison the consequence is total. No pharmacy can lawfully prepare it, so there is no compounded prescription to price and no insurer to appeal to. Set that against our NAD+ price breakdown, where a clinic channel genuinely exists and the interesting question is how far a drip session sits above the raw material. For Epithalon the second column is empty, and the emptiness is the market rather than an omission on our part.
The longevity clinic quote is not a benchmark
This compound is sold on longevity, which changes who is doing the buying and what a price gets compared against. Anti-ageing and longevity practices do market it, which was not true of the other Russian peptides we have covered, and a reader who has been quoted by one arrives here wanting to know whether the quote is fair.
No clinic figure is published on this page, for a simple reason: we have not verified one, and inventing a number to make the vial look cheap would be the same trick the quote itself might be playing. What can be said without inventing anything is where a clinic price comes from. It cannot come from a pharmacy, because no pharmacy can supply the substance. It comes from the same research-supply market you are reading about, plus premises, staff time and a margin.
So the honest comparison is not $25.00 against a clinic number. It is $25.00 against $25.00 plus a service, where the service does not include a prescriber writing a prescription, a pharmacist checking it, or a regulator standing behind the product. That is a different argument from the one a clinic quote implies, and it is the argument worth having before any deposit changes hands. Our page on searching for Epithalon near me works through what to ask a practice that offers it.
What $25.00 does not buy
Everything above is a manufacturing question, and manufacturing is not the thing FDA has raised about this compound.
The agency's position, quoted in full from its page on bulk drug substances that may present significant safety risks: "Compounded drugs containing epitalon may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA has not identified safety-related information regarding epitalon for the proposed route of administration."
Read it closely and you can see exactly how much of the gap a certificate closes. Aggregation and peptide-related impurities are manufacturing and handling problems, and testing is the right instrument for them. A batch assayed at 99.312 percent, screened for endotoxin and showing no microbial growth has addressed a real part of what the agency named. What no certificate produces is human safety data, and the second sentence of that quotation is about the absence of human safety data. A clean result on batch 15-05260628 says the batch was well made. It says nothing about what the compound does in a person. Both halves are true at the same time.
That matters more than usual here because of what the compound is sold on. Telomere and longevity claims circulate widely around Epithalon, resting largely on work from one Russian research group, much of it published in Russian. Reporting that those claims are made is fair. Adopting them is not, and no price on this page should be read as a price for an outcome.
The other thing $25.00 does not buy is recourse. No pharmacist checks the order, no prescriber has seen you, no state board has jurisdiction and no insurer can be appealed to. What exists is the vendor's written policy and a chargeback through your card issuer, which is a reason to pay by card and to keep the order summary and the batch number filed together.
The two numbers to keep
$2.50 per milligram on the label basis and $2.59 on the assayed vial. Carry both. The first is the figure every comparison site will quote, and the second is the one that reflects what the certificate says is in the glass. Where a competing listing publishes no measured net content at all, you are comparing a checked number against an unchecked one, and that is worth noticing before you conclude anyone is cheaper.
The second thing to keep is the absence. There is no prescription price for Epithalon anywhere in the United States, so any page quoting you a pharmacy or insurer figure has invented it. Noticing that is a better test of a source than anything it tells you about the molecule.